The aim of this study was to determine the antitumor activity of 13-cis-retinoic acid as a single agent in patients with advanced renal cell carcinoma. Eligible patients had advanced renal cell carcinoma with bi-dimensionally measurable disease, a Karnofsky performance status of at least 70, life expectancy of greater than three months, no evidence of brain metastases, and treatment with no more than one chemotherapy regimen. Patients were treated with one mg/kg/day of 13-cis-retinoic acid orally. Twenty-six patients were enrolled in this study and 25 were evaluable for response and toxicity. Of the twenty-five evaluable patients, no major responses were achieved. Toxicity was mild, with no patient requiring a dose reduction. At the dose administered in this trial, 13-cis-retinoic acid is inactive as a single agent in renal cell carcinoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1023/a:1005902022076 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Psychiatric comorbidities, inflammatory bowel disease, and urticaria in acne vulgaris patients undergoing isotretinoin treatment: a multicenter cohort study from the TriNetX database.
Arch Dermatol Res
January 2025
Center for Clinical Studies, LTD, Webster, TX, USA.
Use of oral retinoids in the perioperative period by surgical specialty: a literature review.
Arch Dermatol Res
January 2025
Department of Dermatology, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.
Article Synopsis
- This review analyzes the effects of oral retinoids like isotretinoin on wound healing across different surgical fields.
- It raises concerns about the common practice of stopping these medications before surgery, suggesting it's not always necessary based on current research.
- The article calls for personalized decisions regarding retinoid use before surgery and highlights the importance of collaboration between dermatologists and surgeons for better perioperative care.
Maintenance Acne Treatment with Topical Tazarotene after Oral Isotretinoin: Overview and Case Reports.
J Clin Aesthet Dermatol
January 2024
Ms. Miranti is with Riverchase Dermatology and Cosmetic Surgery in Naples, Florida.
Acne is a chronic dermatologic disorder that can require long-term treatment. To prevent recurrence after oral treatment for severe acne, topical maintenance treatment is recommended; however, there is little guidance or research on maintenance regimens. This article briefly summarizes literature on oral isotretinoin and topical retinoids and presents a case series of patients who received tazarotene 0.
View Article and Find Full Text PDFOral Isotretinoin-Associated Ocular Effects and Risk Factors: A Cross-Sectional Study.
Clin Ophthalmol
December 2024
Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.
Article Synopsis
- This study examines the effects of oral isotretinoin on eye health in patients with acne vulgaris, highlighting issues like dryness and discomfort.
- A survey of 489 participants showed a high prevalence of ocular symptoms linked to isotretinoin use, with notable findings including a majority experiencing soreness and blurred vision.
- Key risk factors for worsening eye symptoms included contact lens use and higher isotretinoin dosages, suggesting the need for careful monitoring and preventive measures for patients at risk.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!